Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular Diagnostics

Samuel J Modlin1, Mikael Mansjö2, Jim Werngren2

  • 1Laboratory for Pathogenesis of Clinical Drug Resistance and Persistence, School of Public Health, San Diego State University, San Diego, CA, USA.

Summary

A tuberculosis case resistant to pyrazinamide was misdiagnosed as susceptible due to a minority susceptible subpopulation masking the resistant majority. This highlights limitations in molecular diagnostics for detecting resistant tuberculosis strains.